Glycosphingolipid GM3 prevents albuminuria and podocytopathy induced by anti-nephrin antibody
Abstract Podocytopathy, which is characterized by injury to podocytes, frequently causes proteinuria or nephrotic syndrome. There is currently a paucity of effective therapeutic drugs to treat proteinuric kidney disease. Recent research suggests the possibility that glycosphingolipid GM3 maintains p...
Main Authors: | Nagako Kawashima, Shokichi Naito, Hisatoshi Hanamatsu, Masaki Nagane, Yasuo Takeuchi, Jun-ichi Furukawa, Norimasa Iwasaki, Tadashi Yamashita, Ken-ichi Nakayama |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2022-09-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-022-20265-w |
Similar Items
-
Progression of albuminuria and podocyte injury in focal segmental glomerulosclerosis inhibited by enhanced glycosphingolipid GM3 via valproic acid
by: Nagako Kawashima, et al.
Published: (2023-12-01) -
Alterations of Glycosphingolipid Glycans and Chondrogenic Markers during Differentiation of Human Induced Pluripotent Stem Cells into Chondrocytes
by: Liang Xu, et al.
Published: (2020-12-01) -
Articular cartilage corefucosylation regulates tissue resilience in osteoarthritis
by: Kentaro Homan, et al.
Published: (2024-03-01) -
Advances in total glycomic analysis including sialylated sub-glycan isomers by SALSA method
by: Masaki Kurogochi, et al.
Published: (2025-01-01) -
Refractory diffuse podocytopathy
by: João Oliveira, et al.
Published: (2023-03-01)